| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2005;130:1494-1495
© 2005 The American Association for Thoracic Surgery
Editorial |
National Cardiovascular Center, Osaka, Japan
* Address for reprints: Soichiro Kitamura, MD, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan (Email: skitamur{at}hsp.ncvc.go.jp).
Accumulating clinical
1-3
and basic
4,5
evidence with regard to the internal thoracic artery (ITA) as a viable graft has revealed that this arterial graft for coronary bypass surgery is not a simple conduit to transport blood to the myocardium. It has a character of the major collateral pathway
6
with active biologic potency, such as immunity from the atherosclerotic process, active dilatation and resultant arterial wall remodeling, excellent endothelial secretion of nitric oxide and other biologically active substances, active thinning (string phenomenon) with no-flow patency (nonworking collateral vessel), reestablishment of graft flow depending on the myocardial demand, and the phenomenon that we can call the "self-reparative ability," as published in this issue of the Journal.
7
It has previously been demonstrated that the ITA graft can grow in longitudinal length and transverse diameter in response to somatic growth of children with coronary obstruction.
8
This is the most clear-cut evidence to show that the ITA graft is a viable structure. Moreover, the ITA graft caliber at the anastomotic junction can also grow in children.
9
Probably the same mechanism can work on the stenotic anastomotic sites in adults, with resultant late reduction in the grade of anastomotic stenosis located between the ITA graft and the recipient coronary artery, as shown in the article by Izumi and colleagues.
7
Within 14 days after a bypass operation, ITA flow can show a several-fold increase with a 1.5 times increase in diameter.
10
The ITA graft responds to an acute increase in flow by vasodilatation most importantly by release of nitric oxide, a potent vasodilator derived from the highly active endothelium of the ITA
11
induced by increased shear stress to the arterial wall. Shear stress–induced nitric oxide release occurs in a matter of several seconds through the calcium-dependent constitutive form of nitric oxide synthase activation.
12
The ITA graft can maintain the secretory ability of nitric oxide long after the bypass operation.
13,14
Nitric oxide is released bidirectionally by the endothelium.
15
Extraluminal nitric oxide acts on the underlying vascular smooth muscle regulating the vascular tone and inhibits neointimal proliferation. This action might be effective in making anastomotic stenoses less fibrotic. Intraluminal nitric oxide is released into the blood stream and can be demonstrated long after the bypass operation through activation of the ITA endothelium with acetylcholine.
13
Intraluminally released nitric oxide protects platelet aggregation and adhesion and might have a metabolic effect on the downstream vascular beds.
16
In this sense I think we can call ITA grafting autologous transplantation of the good-quality arterial endothelium into the coronary circulation that has impaired endothelial function with atherosclerosis.
13
Excellent nitric oxide production of the ITA endothelium will prevent further atherosclerotic process for both grafts and grafted coronary arteries, and as a matter of fact, atherosclerotic progression of the coronary artery distal to the ITA graft anastomosis is infrequent.
17
In addition, following revascularization with ITA grafts, coronary vasospastic response to ergonovine is significantly ameliorated or disappears at the segment distal to the ITA graft anastomosis. This phenomenon has been documented by angiography with pharmacologic intervention
18
and can be considered as a proof of the beneficial metabolic effect of the ITA graft, that is an antispastic effect of the ITA graft on vasospastic coronary arteries.
ITA grafts act differently from vein grafts on progression of grafted coronary artery stenosis proximal to the anastomosis. Angiographic progression of grafted coronary artery stenosis is 18% for ITA grafts versus 46% for vein grafts in one series,
3
and 26% versus 45%,
19
12% versus 38%,
20
and 39% versus 67%
17
in other series. These differences are all statistically significant. Progression occurs less frequently in coronary arterial segments bypassed with ITA grafts than in those bypassed with vein grafts. This fact is believed to be attributed to characteristics of the viable ITA graft's function as a major collateral channel. On the basis of these facts, I believe that the ITA graft has a potential metabolic effect that protects the grafted coronary arteries from vasospastic responses and atherosclerotic progression, resulting in longer survival of the patients with more ITA grafts than those without ITA grafts.
21
This salutary metabolic effect of the ITA graft cannot be expected from coronary stents alone. In the present article by Izumi and colleagues,
7
the physiologic response and adaptability of the ITA graft is again demonstrated in terms of the self-reparative ability that can be expected only in a viable graft.
This article also gives rise to an important clinical issue, particularly in the era of off-pump coronary artery bypass, during which anastomotic complications possibly increase. The issue is whether early postoperative angiographic confirmation is needed more than before in the off-pump coronary artery bypass era. Early postoperative angiographic assessment is rather common in Japan but not so in Western counterparts, mainly because of the difference in social insurance coverage. According to the present report, early postoperative angiography is not necessary for the purpose of evaluating ITA graft anastomosis unless the patient shows some types of myocardial ischemia. In addition, intraoperative measurements and evaluation of graft flow with its pattern analysis can provide relatively accurate clues to detect anastomotic failure during an operation. With this technology, surgeons can handle it inside the operating room. In other words, as long as the ITA is adequately handled and anastomosed in the operating room, there is not much to worry about with regard to ITA graft status thereafter. This is certainly good information for surgeons. Also, cardiologists who perform early angiography for the purpose of their own confirmation and sometimes evaluation of surgeons should also realize this fact. However, when a tight (>80%-90%) anastomotic stenosis is found at angiography performed for any reason, I believe that balloon dilatation should be applied because this procedure is safe and long lasting
22
and might prevent the ITA graft occlusion (thrombosis) that occurs at the rate of a few percent, usually as a result of some technical mishap. Simple balloon dilatation is quite satisfactory, with no need for stenting.
| See related article on page 1661.
|
References
Related Article
This article has been cited by other articles:
|
|
 |
|
  H. Nakajima, J. Kobayashi, T. Funatsu, Y. Shimahara, M. Kawamura, A. Kawamura, T. Yagihara, and S. Kitamura Predictive factors for the intermediate-term patency of arterial grafts in aorta no-touch off-pump coronary revascularization Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 711 - 717. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
